All Stories

  1. Refined Mapping of Endothelial Cells, Brain Pericytes and Astrocytes Proteomes via Subcellular Fractionation and DDA Mass Spectrometry
  2. Protective Effects of Extracts from Green Leaves and Rhizomes of Posidonia oceanica (L.) Delile on an In Vitro Model of the Human Blood–Brain Barrier
  3. 25-Hydroxycholesterol attenuates tumor necrosis factor alpha-induced blood-brain barrier breakdown in vitro
  4. Erratum to “CD31 orchestrates metabolic regulation in autophagy pathways of rheumatoid arthritis” [Pharmacol. Res. 207 (2024) 107346]
  5. CD31 orchestrates metabolic regulation in autophagy pathways of rheumatoid arthritis
  6. Secretome of brain microvascular endothelial cells promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage
  7. Enterovirus A71 crosses a human blood–brain barrier model through infected immune cells
  8. Synergistic induction of blood–brain barrier properties
  9. Retraction Note: Secretome of endothelial progenitor cells from stroke patients promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage
  10. Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model
  11. 25-Hydroxycholesterol in health and diseases
  12. BrainBike peptidomimetic enables efficient transport of proteins across brain endothelium
  13. Vesicular Trafficking, a Mechanism Controlled by Cascade Activation of Rab Proteins: Focus on Rab27
  14. ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells
  15. Discovery, Structure–Activity Relationships, and In Vivo Activity of Dihydropyridone Agonists of the Bile Acid Receptor TGR5
  16. High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro
  17. Differential Blood–Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro
  18. Challenges and Opportunities in the Oral Delivery of Recombinant Biologics
  19. Highlighting In Vitro the Role of Brain-like Endothelial Cells on the Maturation and Metabolism of Brain Pericytes by SWATH Proteomics
  20. Impact of Pesticide Residues on the Gut-Microbiota–Blood–Brain Barrier Axis: A Narrative Review
  21. TNFα Activates the Liver X Receptor Signaling Pathway and Promotes Cholesterol Efflux from Human Brain Pericytes Independently of ABCA1
  22. Synergistic induction of blood-brain barrier properties
  23. Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood–Brain Barrier Model Derived from Hematopoietic Stem Cells
  24. Pioglitazone Attenuates the Effects of Peripheral Inflammation in a Human In Vitro Blood–Brain Barrier Model
  25. Challenges and opportunities in the use of transcriptomic characterization of human iPSC-derived BBB models
  26. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model
  27. Antimalarial Drug Discovery: From Quinine to the Most Recent Promising Clinical Drug Candidates
  28. Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells
  29. Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells
  30. A New Class of Bi- and Trifunctional Sugar Oximes as Antidotes against Organophosphorus Poisoning
  31. An In Vitro Human Blood–Brain Barrier Model to Study Breast Cancer Brain Metastasis
  32. The Blood–Brain Barrier, an Evolving Concept Based on Technological Advances and Cell–Cell Communications
  33. A Triple Culture Cell System Modeling the Human Blood-Brain Barrier
  34. RETRACTED ARTICLE: Secretome of endothelial progenitor cells from stroke patients promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage
  35. Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier
  36. Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study
  37. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects
  38. Miniaturization and Automation of a Human In Vitro Blood–Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery
  39. Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound
  40. Role of ABCA7 in Human Health and in Alzheimer’s Disease
  41. Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation
  42. Central nervous system delivery of molecules across the blood-brain barrier
  43. Endothelial Iron Homeostasis Regulates Blood-Brain Barrier Integrity via the HIF2α—Ve-Cadherin Pathway
  44. Correction to: Differential neurovirulence of Usutu viruslineages in mice and neuronal cells
  45. Flow induces barrier and glycocalyx-related genes and negative surface charge in a lab-on-a-chip human blood-brain barrier model
  46. Time-Dependent Internalization of Polymer-Coated Silica Nanoparticles in Brain Endothelial Cells and Morphological and Functional Effects on the Blood-Brain Barrier
  47. Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor
  48. Differential neurovirulence of Usutu virus lineages in mice and neuronal cells
  49. Correction: PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities
  50. Advancing human induced pluripotent stem cell‐derived blood‐brain barrier models for studying immune cell interactions
  51. Endothelial iron homeostasis regulates BBB integrity via the HIF2α – Ve-cadherin pathway
  52. Naphthoquinone–Dopamine Hybrids Inhibit α‐Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate‐Induced Toxicity
  53. Chemoselective Hydrogenation of 6‐Alkynyl‐3‐fluoro‐2‐pyridinaldoximes: Access to First‐in‐Class 6‐Alkyl‐3‐Fluoro‐2‐pyridinaldoxime Scaffolds as New Reactivators of Sarin‐Inhibited Human Acetylcholinesterase with Increased Blood–Brain Barrier Permeability
  54. Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair
  55. First step to the improvement of the blood brain barrier passage of atazanavir encapsulated in sustainable bioorganic vesicles
  56. Zika Virus Infection Promotes Local Inflammation, Cell Adhesion Molecule Upregulation, and Leukocyte Recruitment at the Blood-Brain Barrier
  57. Contribution of brain pericytes in blood–brain barrier formation and maintenance: a transcriptomic study of cocultured human endothelial cells derived from hematopoietic stem cells
  58. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies
  59. The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel
  60. Efficacy Assessment of an Uncharged Reactivator of NOP-Inhibited Acetylcholinesterase Based on Tetrahydroacridine Pyridine-Aldoxime Hybrid in Mouse Compared to Pralidoxime
  61. Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance
  62. Study of Usutu virus neuropathogenicity in mice and human cellular models
  63. Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood–brain barrier model
  64. GM1 Oligosaccharide Crosses the Human Blood–Brain Barrier In Vitro by a Paracellular Route
  65. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
  66. New Lipidyl-Cyclodextrins Obtained by Ring Opening of Methyl Oleate Epoxide Using Ball Milling
  67. Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro
  68. Ketone Bodies Promote Amyloid-β1–40 Clearance in a Human in Vitro Blood–Brain Barrier Model
  69. Nonionotropic Action of Endothelial NMDA Receptors on Blood–Brain Barrier Permeability via Rho/ROCK-Mediated Phosphorylation of Myosin
  70. A High Output Method to Isolate Cerebral Pericytes from Mouse
  71. Transport Studies Using Blood-Brain Barrier In Vitro Models: A Critical Review and Guidelines
  72. PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities
  73. A Miniaturized Pump Out Method for Characterizing Molecule Interaction with ABC Transporters
  74. Granisetron Alleviates Alzheimer’s Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway
  75. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model
  76. Oxysterols and the NeuroVascular Unit (NVU): A far true love with bright and dark sides
  77. PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation
  78. Transient blood–brain barrier disruption is induced by low pulsed electrical fields in vitro: an analysis of permeability and trans-endothelial electric resistivity
  79. A silicon nanomembrane platform for the visualization of immune cell trafficking across the human blood–brain barrier under flow
  80. Corrigendum to “Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration” [Eur. J. Pharm. Biopharm. 127 (2018) 453–461]
  81. Blood-Brain Barrier Cellular Responses Toward Organophosphates: Natural Compensatory Processes and Exogenous Interventions to Rescue Barrier Properties
  82. Exploring in vitro the potential effects of repeated drug treatment on the distribution of other xenobiotics at the human blood-brain barrier (BBB)
  83. HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?
  84. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier
  85. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment
  86. Sodium Transporters Are Involved in Lithium Influx in Brain Endothelial Cells
  87. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration
  88. Food-Derived Hemorphins Cross Intestinal and Blood–Brain Barriers In Vitro
  89. Petits mais costauds
  90. Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers
  91. Brain tissue binding explains discrepancy between in vitro and in vivo methods for assessing blood–brain barrier permeability of chemicals
  92. Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer’s Disease
  93. Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
  94. Modélisation in vitro de la barrière hémato-encéphalique
  95. Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease
  96. Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases
  97. ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood–brain barrier
  98. ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier
  99. Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
  100. In vitro blood–brain barrier permeability predictions for GABA A receptor modulating piperine analogs
  101. β-Cyclodextrins Decrease Cholesterol Release and ABC-Associated Transporter Expression in Smooth Muscle Cells and Aortic Endothelial Cells
  102. Pharmacokinetics and In Vitro Blood-Brain Barrier Screening of the Plant-Derived Alkaloid Tryptanthrin
  103. Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines
  104. Adapting coculture in vitro models of the blood–brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration
  105. Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models
  106. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier
  107. Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid
  108. In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes
  109. Blood–Brain Barrier Proteomics: Towards the Understanding of Neurodegenerative Diseases
  110. Effects of oxysterols on the blood–brain barrier: Implications for Alzheimer’s disease
  111. Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
  112. Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells
  113. Truncated thioredoxin (Trx‐80) promotes pro‐inflammatory macrophages of the M1 phenotype and enhances atherosclerosis
  114. The LXR/RXR Approaches in Alzheimer’s Disease: Is the Blood-Bra in Barrier the Forgotten Partner?
  115. Apolipoprotéine E et intégrité de la barrière hémato-encéphalique
  116. Brain Pericytes ABCA1 Expression Mediates Cholesterol Efflux but not Cellular Amyloid-β Peptide Accumulation
  117. Brain pericytes from stress-susceptible pigs increase blood-brain barrier permeability in vitro
  118. A differential proteomic approach identifies structural and functional components that contribute to the differentiation of brain capillary endothelial cells
  119. Modelling the Neurovascular Unit and the Blood-Brain Barrier with the Unique Function of Pericytes
  120. La barrière hémato-encéphalique
  121. Erratum
  122. The Mysterious Link between Cholesterol and Alzheimer?s Disease: Is the Blood-Brain Barrier a Suspect?
  123. Apical-to-Basolateral Transport of Amyloid-β Peptides through Blood-Brain Barrier Cells is Mediated by the Receptor for Advanced Glycation End-Products and is Restricted by P-Glycoprotein
  124. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood–brain barrier: Use of an in vitro model
  125. Physiological Pathway for Low-Density Lipoproteins across the Blood-Brain Barrier: Transcytosis through Brain Capillary Endothelial Cells In Vitro
  126. BMP2 and BMP6 control p57Kip2 expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes
  127. UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis